$9B Verdict Hammers Takeda, Eli Lilly In Actos Bellwether

By Kat Greene (April 8, 2014, 12:34 AM EDT) -- A Louisiana federal jury on Monday ordered Takeda Pharmaceutical Co. Ltd. and Eli Lilly & Co. to pay more than $9 billion in damages to a couple, in a bellwether trial over allegations the companies hid the cancer risks of diabetes drug Actos to keep sales high.

Terrence and Susan Allen won the judgment late Monday, in the first federal jury decision in multidistrict litigation against Asia's largest drug company and its American partner. The jury hit Takeda with $6 billion in punitive damages and Eli Lilly with $3 billion. The companies, which jointly marketed the drug, also will split payment...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!